• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

欧洲肝细胞癌中p53蛋白的积累并不总是依赖于p53基因突变。

p53 protein accumulation in European hepatocellular carcinoma is not always dependent on p53 gene mutation.

作者信息

Bourdon J C, D'Errico A, Paterlini P, Grigioni W, May E, Debuire B

机构信息

Centre National de la Recherche Scientifique, Institut de Recherche sur le Cancer, Villejuif, France.

出版信息

Gastroenterology. 1995 Apr;108(4):1176-82. doi: 10.1016/0016-5085(95)90217-1.

DOI:10.1016/0016-5085(95)90217-1
PMID:7698586
Abstract

BACKGROUND/AIMS: Immunohistochemical reactivity for p53 protein is common in various human malignancies and often related to p53 gene mutation. However, in some tumor types, accumulation of wild-type p53 has been shown. Previously, we analyzed 96 European hepatocellular carcinomas using immunohistochemistry and found that 31% of these tumors overexpressed p53 in the cell nucleus. The aim of the present study was to establish whether p53 positivity correlates with the presence of structural p53 gene abnormalities in European hepatocellular carcinoma.

METHODS

DNA from 20 tumors, 10 with strong immunostaining and 10 with undetectable staining for p53, was extracted from frozen sections, and the entire coding portion of the p53 gene was sequenced.

RESULTS

Five of the 10 tumors containing high levels of p53 protein showed missense point mutations. The remaining 5 tumors with high p53 levels showed the wild-type coding sequence. One of the 10 tumors containing undetectable levels of p53 protein had a 1-base pair deletion in the splice acceptor site of intron 4.

CONCLUSIONS

The results strongly suggest that, in European hepatocellular carcinomas, stabilization of the p53 protein depends on factors other than p53 gene mutation, such as binding to other molecules of cellular or viral origin.

摘要

背景/目的:p53蛋白的免疫组化反应性在各种人类恶性肿瘤中很常见,且常与p53基因突变有关。然而,在某些肿瘤类型中,已显示有野生型p53的积累。此前,我们使用免疫组化分析了96例欧洲肝细胞癌,发现其中31%的肿瘤在细胞核中过表达p53。本研究的目的是确定在欧洲肝细胞癌中p53阳性是否与p53基因结构异常的存在相关。

方法

从20个肿瘤(10个p53免疫染色强阳性和10个p53染色不可检测)的冰冻切片中提取DNA,并对p53基因的整个编码部分进行测序。

结果

10个含有高水平p53蛋白的肿瘤中有5个显示错义点突变。其余5个p53水平高的肿瘤显示野生型编码序列。10个含有不可检测水平p53蛋白的肿瘤中有1个在内含子4的剪接受体位点有1个碱基对缺失。

结论

结果强烈表明,在欧洲肝细胞癌中,p53蛋白的稳定取决于p53基因突变以外的因素,如与细胞或病毒来源的其他分子结合。

相似文献

1
p53 protein accumulation in European hepatocellular carcinoma is not always dependent on p53 gene mutation.欧洲肝细胞癌中p53蛋白的积累并不总是依赖于p53基因突变。
Gastroenterology. 1995 Apr;108(4):1176-82. doi: 10.1016/0016-5085(95)90217-1.
2
Low incidence of p53 mutations in European hepatocellular carcinomas with heterogeneous mutation as a rare event.欧洲肝细胞癌中p53突变发生率低,异质性突变作为罕见事件。
J Hepatol. 1995 Oct;23(4):412-9. doi: 10.1016/0168-8278(95)80199-5.
3
Overexpression and point mutations of p53 tumor suppressor gene in hepatocellular carcinomas in Hong Kong Chinese people.香港华人肝细胞癌中p53肿瘤抑制基因的过表达和点突变
Cancer. 1994 Jul 1;74(1):30-7. doi: 10.1002/1097-0142(19940701)74:1<30::aid-cncr2820740107>3.0.co;2-4.
4
Genetic alterations at the splice junction of p53 gene in human hepatocellular carcinoma.人类肝细胞癌中p53基因剪接位点的基因改变。
Hepatology. 1994 Jan;19(1):122-8.
5
Loss of p53 transcriptional activity in hepatocellular carcinoma evaluated by yeast-based functional assay: comparison with p53 immunohistochemistry.
Hum Pathol. 2004 Mar;35(3):350-6. doi: 10.1016/j.humpath.2003.09.014.
6
Mutations in the tumor suppressor gene p53 in human liver cancer induced by alpha-particles.α粒子诱导的人类肝癌中肿瘤抑制基因p53的突变
Cancer Epidemiol Biomarkers Prev. 1995 Oct-Nov;4(7):765-70.
7
Correlation of immunohistochemical staining and mutations of p53 in human hepatocellular carcinoma.人肝细胞癌中p53免疫组化染色与突变的相关性
Oncol Rep. 2000 Mar-Apr;7(2):353-6.
8
Analysis of the p53 tumor-suppressor gene in hepatocellular carcinomas from Britain.英国肝细胞癌中p53肿瘤抑制基因的分析。
Hepatology. 1992 Dec;16(6):1362-6. doi: 10.1002/hep.1840160610.
9
High levels of p53 protein expression do not correlate with p53 mutations in hepatocellular carcinoma.高水平的p53蛋白表达与肝细胞癌中的p53突变不相关。
J Viral Hepat. 2004 Nov;11(6):502-10. doi: 10.1111/j.1365-2893.2004.00541.x.
10
p53 mutation and overexpression in hepatocellular carcinoma and dysplastic nodules in the liver.p53在肝细胞癌及肝脏发育异常结节中的突变与过表达。
Virchows Arch. 1998 Jan;432(1):27-32. doi: 10.1007/s004280050130.

引用本文的文献

1
Liver Lipids of Patients with Hepatitis B and C and Associated Hepatocellular Carcinoma.乙型肝炎和丙型肝炎患者及其相关肝细胞癌的肝脏脂质。
Int J Mol Sci. 2021 May 18;22(10):5297. doi: 10.3390/ijms22105297.
2
TP53 Mutation in Correlation to Immunohistochemical Expression of P53 Protein in Patients with Hepatocellular Carcinoma.肝细胞癌患者中TP53突变与P53蛋白免疫组化表达的相关性
Open Access Maced J Med Sci. 2018 Jun 25;6(7):1181-1186. doi: 10.3889/oamjms.2018.278. eCollection 2018 Jul 20.
3
Ribosomopathy-like properties of murine and human cancers.
小鼠和人类癌症的核糖体病样特性。
PLoS One. 2017 Aug 18;12(8):e0182705. doi: 10.1371/journal.pone.0182705. eCollection 2017.
4
Immunohistochemical Determination of p53 Protein Overexpression for Predicting p53 Gene Mutations in Hepatocellular Carcinoma: A Meta-Analysis.免疫组织化学检测p53蛋白过表达以预测肝细胞癌中p53基因突变:一项荟萃分析
PLoS One. 2016 Jul 18;11(7):e0159636. doi: 10.1371/journal.pone.0159636. eCollection 2016.
5
Clinical impact of TP53 alterations in adrenocortical carcinomas.TP53 改变在肾上腺皮质癌中的临床影响。
Langenbecks Arch Surg. 2012 Feb;397(2):209-16. doi: 10.1007/s00423-011-0868-6. Epub 2011 Dec 29.
6
Detection of mutant p53 in hepatocellular cancer from Turkey and its correlation with clinicopathologic parameters.土耳其肝细胞癌中突变型p53的检测及其与临床病理参数的相关性。
Dig Dis Sci. 2003 May;48(5):865-9. doi: 10.1023/a:1023031008757.
7
Isolation and characterization of a human hepatic epithelial-like cell line (AKN-1) from a normal liver.从正常肝脏中分离并鉴定一种人肝上皮样细胞系(AKN-1)。
In Vitro Cell Dev Biol Anim. 1999 Apr;35(4):190-7. doi: 10.1007/s11626-999-0026-4.
8
Genetic alterations in hepatocellular carcinomas: association between loss of chromosome 4q and p53 gene mutations.肝细胞癌中的基因改变:4号染色体q臂缺失与p53基因突变之间的关联。
Br J Cancer. 1999 Apr;80(1-2):59-66. doi: 10.1038/sj.bjc.6690321.
9
Nuclear accumulation of p53 correlates significantly with clinical features and inversely with the expression of the cyclin-dependent kinase inhibitor p21(WAF1/CIP1) in pancreatic cancer.在胰腺癌中,p53的核内积聚与临床特征显著相关,且与细胞周期蛋白依赖性激酶抑制剂p21(WAF1/CIP1)的表达呈负相关。
Br J Cancer. 1997;76(3):299-305. doi: 10.1038/bjc.1997.382.
10
p53 exon 5 mutations as a prognostic indicator of shortened survival in non-small-cell lung cancer.p53基因第5外显子突变作为非小细胞肺癌患者生存时间缩短的预后指标。
Br J Cancer. 1997;76(1):44-51. doi: 10.1038/bjc.1997.334.